Related Experiment Video
Updated: May 6, 2026
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Choosing Appropriate Candidates for Left Atrial Appendage Occlusion
Chengxiang Zhang1, Hao Lu1, Yuansong Zhu2
1Department of General Medicine, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China.
Insights
Atrial fibrillation (AF) stroke risk can be managed with left atrial appendage occlusion (LAAO). This review details patient selection criteria for LAAO, offering a crucial alternative to oral anticoagulation.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Cardiology
Background:
- Atrial fibrillation (AF) is a common arrhythmia, increasing stroke risk by up to fivefold.
- Oral anticoagulation is standard for stroke prevention in nonvalvular AF.
- Left atrial appendage occlusion (LAAO) offers an alternative for patients intolerant to anticoagulation.
Purpose of the Study:
- To review current recommendations for patient selection in LAAO procedures.
- To identify key factors for pre- and post-procedural evaluation in LAAO.
- To discuss advancements in LAAO patient selection.
Main Methods:
- Literature review of current guidelines and clinical studies.
- Analysis of factors influencing LAAO candidacy.
- Discussion of emerging trends in LAAO patient selection.
Main Results:
- Patient selection for LAAO involves a complex assessment of clinical factors.
- No single guideline universally dictates LAAO candidacy.
- Ongoing research aims to refine selection criteria and improve outcomes.
Conclusions:
- Left atrial appendage occlusion is a valuable stroke prevention strategy in select AF patients.
- Comprehensive patient evaluation is critical for successful LAAO.
- Future advancements will likely enhance the precision of LAAO candidate selection.
Abstract:
Atrial fibrillation (AF) is one the most prevalent arrhythmias globally and is associated with a significantly higher risk of morbidity and mortality, including an up to five-fold increase in risk of stroke. While oral anticoagulation therapy remains the standard approach for stroke prevention in nonvalvular AF, left atrial appendage occlusion (LAAO) has emerged as a viable alternative for patients who are intolerant to long-term oral anticoagulation therapy. However, selecting appropriate candidates for LAAO requires a comprehensive evaluation that considers various clinical factors, although this presents a challenge in clinical practice. This review aims to provide an overview of the current recommendations for patient selection in LAAO procedures and the key factors that need to be considered both before and after the procedure, as well as the ongoing advancements in this field that may facilitate the selection of patients for LAAO.
